Stock Analysis on Net

Abbott Laboratories (NYSE:ABT)

$24.99

DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin
Quarterly Data

Microsoft Excel

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Two-Component Disaggregation of ROE

Abbott Laboratories, decomposition of ROE (quarterly data)

Microsoft Excel
ROE = ROA × Financial Leverage
Dec 31, 2025 = ×
Sep 30, 2025 = ×
Jun 30, 2025 = ×
Mar 31, 2025 = ×
Dec 31, 2024 = ×
Sep 30, 2024 = ×
Jun 30, 2024 = ×
Mar 31, 2024 = ×
Dec 31, 2023 = ×
Sep 30, 2023 = ×
Jun 30, 2023 = ×
Mar 31, 2023 = ×
Dec 31, 2022 = ×
Sep 30, 2022 = ×
Jun 30, 2022 = ×
Mar 31, 2022 = ×

Based on: 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).


The financial performance, as indicated by the provided metrics, demonstrates considerable fluctuation over the observed period. Return on Equity (ROE) exhibits a pronounced cyclical pattern, initially decreasing from 2022 through 2023, then experiencing a substantial increase in late 2024, followed by a sharp decline in early 2025. This ROE movement is directly influenced by the interplay between Return on Assets (ROA) and Financial Leverage.

Return on Assets (ROA)
ROA generally decreased from the first quarter of 2022 through the first quarter of 2023, falling from 10.44% to 7.87%. A slight recovery occurred in subsequent quarters of 2023, but ROA remained relatively stable around the 7-8% range until the fourth quarter of 2024, when it surged to 16.46% and 16.58% in the following quarter. A significant drop is then observed in the first quarter of 2025, returning to 7.52%.
Financial Leverage
Financial Leverage remained relatively stable between 1.90 and 2.09 throughout most of the period. A gradual downward trend is apparent from the first quarter of 2022 to the first quarter of 2025, decreasing from 2.09 to 1.66. The final quarter of 2025 shows a slight increase to 1.66, but remains below prior levels. This suggests a decreasing reliance on debt financing.
ROE Decomposition
The initial decline in ROE from 2022 to 2023 is primarily attributable to the decrease in ROA, despite relatively stable Financial Leverage. The substantial increase in ROE observed in late 2024 is driven by the dramatic rise in ROA, with Financial Leverage continuing its gradual decline. The subsequent collapse in ROE during the first quarter of 2025 is almost entirely due to the precipitous fall in ROA, as Financial Leverage remains relatively consistent.

The observed patterns suggest a strong correlation between ROA and ROE. Fluctuations in operational efficiency, as reflected by ROA, have a magnified impact on shareholder returns due to the consistent application of financial leverage. The decreasing trend in Financial Leverage indicates a potential shift in capital structure strategy, though its impact on ROE has been secondary to the ROA fluctuations during the analyzed timeframe.


Three-Component Disaggregation of ROE

Abbott Laboratories, decomposition of ROE (quarterly data)

Microsoft Excel
ROE = Net Profit Margin × Asset Turnover × Financial Leverage
Dec 31, 2025 = × ×
Sep 30, 2025 = × ×
Jun 30, 2025 = × ×
Mar 31, 2025 = × ×
Dec 31, 2024 = × ×
Sep 30, 2024 = × ×
Jun 30, 2024 = × ×
Mar 31, 2024 = × ×
Dec 31, 2023 = × ×
Sep 30, 2023 = × ×
Jun 30, 2023 = × ×
Mar 31, 2023 = × ×
Dec 31, 2022 = × ×
Sep 30, 2022 = × ×
Jun 30, 2022 = × ×
Mar 31, 2022 = × ×

Based on: 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).


The three-component DuPont analysis reveals fluctuating performance over the observed period. Initially, Return on Equity (ROE) demonstrated strength, peaking in the first half of 2022, before experiencing a decline through 2023. A significant surge in ROE is then observed in the first three quarters of 2024, followed by a substantial decrease in the final quarter of 2024 and the first two quarters of 2025.

Net Profit Margin
The Net Profit Margin exhibited volatility. It increased from 17.35% in March 2022 to 18.78% in June 2022, then decreased to 15.88% by December 2022. A continued downward trend was observed through June 2023, reaching 12.83%. However, the margin experienced a dramatic increase in December 2024, reaching 31.95%, before falling back to 14.72% by December 2025. This suggests significant, but potentially temporary, improvements in profitability during late 2024.
Asset Turnover
Asset Turnover remained relatively stable between 0.55 and 0.62 throughout most of the period. A slight decline was observed from 0.60 in March 2022 to 0.51 in December 2025, indicating a gradual decrease in the efficiency of asset utilization. The changes are relatively small, suggesting consistent operational efficiency, albeit with a minor long-term downward trend.
Financial Leverage
Financial Leverage demonstrated a consistent, albeit gradual, decline over the period. Starting at 2.09 in March 2022, it decreased to 1.66 by December 2025. This indicates a reduction in the company’s reliance on debt financing. The decrease is steady, suggesting a deliberate strategy to lower financial risk.

The initial decline in ROE from 2022 to 2023 appears to be driven by decreasing Net Profit Margin, with Asset Turnover and Financial Leverage contributing to a lesser extent. The substantial increase in ROE during 2024 is almost entirely attributable to the dramatic rise in Net Profit Margin. The subsequent decline in ROE at the end of 2024 and into 2025 is a direct result of the sharp decrease in Net Profit Margin, despite continued reductions in Financial Leverage. The relatively stable Asset Turnover suggests that changes in sales efficiency did not significantly impact overall ROE fluctuations.

The interplay between these three components highlights the significant influence of profitability on overall returns. While the company has been reducing its financial leverage, its ROE is highly sensitive to changes in its Net Profit Margin.


Five-Component Disaggregation of ROE

Abbott Laboratories, decomposition of ROE (quarterly data)

Microsoft Excel
ROE = Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Financial Leverage
Dec 31, 2025 = × × × ×
Sep 30, 2025 = × × × ×
Jun 30, 2025 = × × × ×
Mar 31, 2025 = × × × ×
Dec 31, 2024 = × × × ×
Sep 30, 2024 = × × × ×
Jun 30, 2024 = × × × ×
Mar 31, 2024 = × × × ×
Dec 31, 2023 = × × × ×
Sep 30, 2023 = × × × ×
Jun 30, 2023 = × × × ×
Mar 31, 2023 = × × × ×
Dec 31, 2022 = × × × ×
Sep 30, 2022 = × × × ×
Jun 30, 2022 = × × × ×
Mar 31, 2022 = × × × ×

Based on: 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).


The five-component DuPont analysis reveals significant fluctuations in Return on Equity (ROE) over the observed period. Initial values demonstrate a relatively strong ROE, which subsequently experiences a decline before a substantial increase, followed by another decrease. This analysis details the drivers behind these changes, examining trends in Tax Burden, Interest Burden, EBIT Margin, Asset Turnover, and Financial Leverage.

Tax Burden
The Tax Burden remained consistently high, generally around 0.85, from March 31, 2022, through September 30, 2024. A notable spike to 1.91 occurred in December 31, 2024, decreasing to 0.77 by December 31, 2025. This large fluctuation suggests a significant change in tax-related items or accounting adjustments during that period, potentially impacting net income.
Interest Burden
The Interest Burden exhibited relative stability, fluctuating narrowly between 0.91 and 0.95 throughout most of the period. This indicates consistent debt management practices and a predictable impact of interest expenses on earnings. There is no significant trend observed.
EBIT Margin
The EBIT Margin initially demonstrated strength, peaking at 23.22 in June 30, 2022, before a gradual decline to 17.11 by June 30, 2023. A subsequent recovery began, reaching 20.21 by December 31, 2025. This suggests evolving operational efficiency and pricing power, with periods of margin compression followed by improvement. The recent increase indicates a positive trend in core profitability.
Asset Turnover
Asset Turnover showed a consistent downward trend, decreasing from 0.60 in March 31, 2022, to 0.51 by December 31, 2025. This indicates decreasing efficiency in utilizing assets to generate revenue. The company appears to be generating less revenue per dollar of assets over time, which could be due to factors such as increased inventory levels or underutilized capacity.
Financial Leverage
Financial Leverage generally decreased over the period, moving from 2.09 in March 31, 2022, to 1.66 by December 31, 2025. This suggests a reduction in the company’s reliance on debt financing. While lower leverage reduces financial risk, it can also limit potential returns if debt is used effectively.

The initial decline in ROE from 2022 to 2023 appears driven by a combination of decreasing EBIT Margin and Asset Turnover, partially offset by stable Tax and Interest Burdens and decreasing Financial Leverage. The dramatic increase in ROE observed in December 31, 2024, is largely attributable to the outlier Tax Burden value. The subsequent decline in ROE by December 31, 2025, is primarily due to the continued decrease in Asset Turnover and a return to a more typical Tax Burden, despite improvements in EBIT Margin and a continued reduction in Financial Leverage. The interplay between these components highlights the complex factors influencing overall profitability and shareholder returns.


Two-Component Disaggregation of ROA

Abbott Laboratories, decomposition of ROA (quarterly data)

Microsoft Excel
ROA = Net Profit Margin × Asset Turnover
Dec 31, 2025 = ×
Sep 30, 2025 = ×
Jun 30, 2025 = ×
Mar 31, 2025 = ×
Dec 31, 2024 = ×
Sep 30, 2024 = ×
Jun 30, 2024 = ×
Mar 31, 2024 = ×
Dec 31, 2023 = ×
Sep 30, 2023 = ×
Jun 30, 2023 = ×
Mar 31, 2023 = ×
Dec 31, 2022 = ×
Sep 30, 2022 = ×
Jun 30, 2022 = ×
Mar 31, 2022 = ×

Based on: 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).


The financial performance, as indicated by the two-component disaggregation of Return on Assets (ROA), exhibits notable fluctuations over the observed period. A general trend of declining profitability and efficiency, followed by a significant surge and subsequent decline, is apparent. The analysis focuses on Net Profit Margin and Asset Turnover to understand the drivers of these ROA changes.

Net Profit Margin
The Net Profit Margin demonstrates considerable volatility. From March 31, 2022, to December 31, 2022, it decreased from 17.35% to 15.88%. The first half of 2023 saw a continued decline, reaching a low of 12.83% in June 2023. However, a substantial increase is observed in the latter half of 2024, peaking at 31.95% in December 2024, before falling back to 14.72% by December 2025. This suggests a period of significantly improved profitability followed by a return to more moderate levels.
Asset Turnover
Asset Turnover remained relatively stable between March 31, 2022, and December 31, 2023, fluctuating between 0.55 and 0.62. A gradual decline is then observed, reaching a low of 0.51 in both March 2025 and December 2025. This indicates a decreasing efficiency in utilizing assets to generate sales. The consistency of this ratio prior to 2024 suggests a stable operational efficiency, which then deteriorated.
Return on Assets (ROA)
ROA mirrored the trends in its component ratios. It decreased from 10.44% in March 2022 to 7.04% in June 2023, reflecting the combined impact of declining profitability and relatively stable asset turnover. The dramatic increase in Net Profit Margin in late 2024 drove a corresponding surge in ROA, reaching 16.46% in December 2024. However, the subsequent decline in both Net Profit Margin and Asset Turnover resulted in a decrease in ROA to 7.52% by December 2025. This highlights the strong correlation between ROA and Net Profit Margin, with Asset Turnover playing a secondary, but still influential, role.

The period between March 2024 and December 2025 demonstrates a particularly interesting dynamic. While the initial surge in ROA was driven by a substantial improvement in profitability, the inability to maintain this level, coupled with a slight decrease in asset utilization, led to a significant reduction in overall performance. Further investigation into the factors driving the Net Profit Margin fluctuations would be beneficial.


Four-Component Disaggregation of ROA

Abbott Laboratories, decomposition of ROA (quarterly data)

Microsoft Excel
ROA = Tax Burden × Interest Burden × EBIT Margin × Asset Turnover
Dec 31, 2025 = × × ×
Sep 30, 2025 = × × ×
Jun 30, 2025 = × × ×
Mar 31, 2025 = × × ×
Dec 31, 2024 = × × ×
Sep 30, 2024 = × × ×
Jun 30, 2024 = × × ×
Mar 31, 2024 = × × ×
Dec 31, 2023 = × × ×
Sep 30, 2023 = × × ×
Jun 30, 2023 = × × ×
Mar 31, 2023 = × × ×
Dec 31, 2022 = × × ×
Sep 30, 2022 = × × ×
Jun 30, 2022 = × × ×
Mar 31, 2022 = × × ×

Based on: 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).


The financial performance, as indicated by the four-component DuPont analysis, reveals notable shifts over the observed period. Initially, from March 2022 through December 2022, Return on Assets (ROA) experienced a gradual decline. This trend reversed in early 2023, but then stabilized before a significant outlier in December 2024, followed by a sharp decline into early 2025. A detailed examination of the contributing factors reveals key drivers of these fluctuations.

Tax Burden
The tax burden remained relatively stable between March 2022 and December 2023, fluctuating within a narrow range of 0.82 to 0.86. However, a substantial increase is observed in December 2024 (1.91) and March 2025 (1.84), before decreasing significantly to 0.77 by December 2025. This volatility suggests potential changes in tax liabilities or effective tax rates during these periods.
Interest Burden
The interest burden demonstrated a slight decreasing trend from 0.94 in March 2022 to 0.91 between June 2023 and December 2023. It then increased slightly to 0.93 in December 2024, and remained stable at 0.94 through December 2025. This indicates a generally consistent capacity to cover interest expenses with earnings.
EBIT Margin
The EBIT margin exhibited fluctuations throughout the period. It peaked at 23.22% in June 2022, followed by a consistent decline to 17.11% by June 2023. A modest recovery occurred through December 2024, reaching 18.05%, before increasing to 20.21% by December 2025. This suggests varying operational efficiency and pricing power over time.
Asset Turnover
Asset turnover showed a gradual decline from 0.60 in March 2022 to 0.51 in December 2025. This indicates a decreasing efficiency in generating sales from the company’s asset base. The most significant drop occurred between March 2023 and December 2025, suggesting a potential slowdown in sales relative to asset investment.

The initial decline in ROA from March 2022 to December 2022 appears primarily driven by a combination of decreasing EBIT margin and asset turnover, partially offset by stable tax and interest burdens. The stabilization of ROA in early 2023 reflects a leveling off of these trends. The dramatic increase in ROA in December 2024 is largely attributable to the outlier tax burden, but this effect is short-lived, as ROA declines sharply in subsequent periods. The decline in ROA from December 2024 to December 2025 is primarily attributable to the decrease in asset turnover, coupled with a significant decrease in the tax burden. The interplay between these components highlights the sensitivity of overall profitability to changes in operational efficiency, asset utilization, and tax-related factors.


Disaggregation of Net Profit Margin

Abbott Laboratories, decomposition of net profit margin ratio (quarterly data)

Microsoft Excel
Net Profit Margin = Tax Burden × Interest Burden × EBIT Margin
Dec 31, 2025 = × ×
Sep 30, 2025 = × ×
Jun 30, 2025 = × ×
Mar 31, 2025 = × ×
Dec 31, 2024 = × ×
Sep 30, 2024 = × ×
Jun 30, 2024 = × ×
Mar 31, 2024 = × ×
Dec 31, 2023 = × ×
Sep 30, 2023 = × ×
Jun 30, 2023 = × ×
Mar 31, 2023 = × ×
Dec 31, 2022 = × ×
Sep 30, 2022 = × ×
Jun 30, 2022 = × ×
Mar 31, 2022 = × ×

Based on: 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).


The period under review demonstrates fluctuating performance across key profitability metrics. A notable divergence emerges in the latter portion of the observed timeframe, particularly concerning the Net Profit Margin, which experiences a substantial increase before reverting to levels more consistent with earlier periods.

Tax Burden
The Tax Burden remained relatively stable between March 2022 and December 2022, fluctuating between 0.83 and 0.85. A significant increase is then observed in December 2023, reaching 1.91, followed by a decline through December 2025, ending at 0.77. This volatility suggests potential changes in tax planning strategies or applicable tax rates.
Interest Burden
The Interest Burden exhibits a high degree of consistency throughout the analyzed period, generally remaining between 0.91 and 0.95. Minor fluctuations are present, but the overall trend is remarkably stable, indicating consistent financial leverage and interest expense management.
EBIT Margin
The EBIT Margin initially demonstrates variability, peaking at 23.22 in June 2022 before declining to 18.24 by March 2023. It then shows a modest recovery, reaching 20.21 by December 2025. This pattern suggests sensitivity to operational performance and cost controls. The overall trend is relatively flat, with fluctuations around the 17-20% range for most of the period.
Net Profit Margin
The Net Profit Margin mirrors the trend of the EBIT Margin initially, declining from 18.78 in June 2022 to 12.83 in June 2023. However, a dramatic increase occurs in December 2023, reaching 31.95, and remaining elevated through September 2025 (ranging from 31.88 to 32.43). A substantial decrease is then observed in December 2025, falling to 14.72. This significant fluctuation warrants further investigation to determine the underlying drivers, potentially including one-time gains, changes in the tax burden, or shifts in the cost structure. The large increase and subsequent decrease suggest a non-recurring event significantly impacted profitability in late 2023 and early 2025.

The disaggregation reveals that changes in the Net Profit Margin are not consistently correlated with changes in either the Tax Burden or the Interest Burden. The substantial increase in Net Profit Margin in late 2023 and early 2025 appears to be driven by factors beyond these two components, likely related to the EBIT Margin and potentially other non-operating items. The recent decline in December 2025, coupled with the simultaneous decrease in Tax Burden, suggests a significant operational or financial event occurred.